...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use
【24h】

Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use

机译:怀孕和婴儿结果包括慢性炎症性关节炎或牛皮癣的女性主要先天性畸形,有和没有Etanercept使用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PurposeObjectives were to quantify prevalence estimates of pregnancy and infant outcomes including major congenital malformations (MCMs) by etanercept (ETN) exposure among infants born to women with chronic inflammatory arthritis (cIA) or psoriasis (PsO).
机译:目的的是为了量化怀孕和婴儿结果的患病率和婴儿结果,包括依赖于患有慢性炎症性关节炎(CIA)或牛皮癣(PSO)的婴儿的婴儿的主要先天性畸形(MCMS)。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号